TNF and metabolic dysfunction-associated steatotic liver disease: Moreover, the role of medical treatments, including glucocorticoids, immunomodulators, and tumor necrosis factor-α inhibitors, in the pathogenesis of NAFLD in IBD also remains unclear [17].